Copyright
©The Author(s) 2022.
World J Cardiol. Jun 26, 2022; 14(6): 343-354
Published online Jun 26, 2022. doi: 10.4330/wjc.v14.i6.343
Published online Jun 26, 2022. doi: 10.4330/wjc.v14.i6.343
Table 4 Gross and histopathological findings of the heart after coronavirus disease 2019 mRNA vaccination
Ref. | No. of cases (age, sex)/vaccine | Gross findings | Histopathological findings |
Ameratunga et al[24] | 1 (57, F)/Pfizer-BioNTech | The heart was normal without pericardial effusion and intra-cardiac thrombosis. There was a large thymoma mass (710 g) in the left pleural cavity | The heart sections showed fulminant necrotizing eosinophilic myocarditis. There were multifocal aggregates of lymphoid cells, histiocytes, and abundant eosinophils with focal myocyte necrosis in the free walls of both ventricles, interventricular septum, and around the conduction system (sino-atrial and atrioventricular nodes) |
Choi et al[25] | 1 (22, M)/Pfizer-BioNTech | The heart weighed 470 g with multiple petechial hemorrhages on its surface. The pericardium was smooth with no fibrin deposition or exudate. The coronary arteries were patent, and the heart valves were unremarkable | The myocardial sections showed a diffuse inflammatory infiltration with neutrophils and histiocytes predominance. The inflammatory infiltrates dominant in the atria and around the sinoatrial and atrioventricular nodes with no inflammatory cells in the ventricular muscles |
Schneider et al[26] | 1 (65, M)/Pfizer-BioNTech | The heart showed severe coronary sclerosis, massive cardiac hypertrophy, myocardial infarction scars | The myocardial sections showed myocarditis with lymphocytic and plasmacytoid infiltration of the perivascular space and the myocardium |
- Citation: Leowattana W, Leowattana T. COVID-19 vaccination and cardiac dysfunction. World J Cardiol 2022; 14(6): 343-354
- URL: https://www.wjgnet.com/1949-8462/full/v14/i6/343.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i6.343